Sudden PSA rise to ≥20 ng/ml and prostate cancer diagnosis in the United States: A population-based study.

The incidence of high-risk PC in a screened population is low (<0.1%). Our findings suggest that systematic screening cannot eliminate all PC deaths and provide an estimate for the risk of the rapid development of high-risk cancers that is comparable to that observed in active surveillance populations.